Unexpected haemorrhage location after intravenous thrombolysis for left middle cerebral artery infarction
Case 1
A 63-year-old right-handed man with chronic hypertension presented at the emergency department with sudden onset of right limb weakness and rightsided drooling after standing up abruptly. His right upper limb was significantly weaker than his right lower limb. The infarction was clinically localised to the left corona radiata by a neurologist. Emergency brain computed tomography (CT) showed no haemorrhage. The patient's initial National Institutes of Health Stroke Scale (NIHSS) score was 5. Blood pressure was 175/95 mmHg. Since blood examinations did not s how co ag ulop at hy o r d ys cr as ia , in tr aven ou s recombinant tissue plasminogen activator (rtPA) of 0.9 mg/kg was administered according to his body weight (69 kg) within 2 hours of symptom onset ( Figure 1a ). The patient's blood pressure increased to 190/103 mmHg after starting thrombolytic therapy, then labetalol 12.5 mg was administered intravenously. However, the blood pressure further increased to 204/115 mmHg at 3 hours post-initiation of thrombolytic therapy. The patient suddenly developed anisocoria, and an emergency brain CT revealed midbrain and pontine haemorrhages (Figure 1b ).
Brain magnetic resonance imaging (MRI) confirmed the initial diagnosis of left corona radiata ischaemic infarction and also revealed recent brainstem haemorrhage and leukoaraiosis (diffuse white matter abnormalities detected on CT or MRI scans). Intracranial and extracranial magnetic resonance angiography (MRA) revealed no aneurysm or vascular malformation except for tortuous vertebrobasilar arteries ( Figure 2 ).
Case 2
A 64-year-old right-handed man with chronic h y per t ens io n wa s bro u g ht t o o u r emer g en c y department with sudden onset of right limb weakness and slurred speech while walking. The patient's blood pressure on arrival to the emergency department was 270/132 mmHg. He was drowsy but could be woken by voice. The NIHSS score was 21 and brain CT Labetalol was prescribed to reduce the systolic blood pressure to 150 mmHg. Thrombolytic therapy with rtPA was administered 2 hours after symptom onset, but the patient became agitated during rtPA infusion with blood pressure of 220/100 mmHg. Emergency brain CT (Figure 4 ) showed haemorrhages at pons, midbrain, and right thalamus. Thrombolytic therapy was stopped 12 minutes after start of rtPA infusion.
Dilated right pupil, mid-sized fixed left pupil, spasticity, and bilateral limbs extensor response were noted after the brainstem haemorrhage. The patient died on the second day of infarction. 
Discussion
Researchers have studied risk factors and aetiology of sy mpt oma tic intr acereb ra l h aemorr hag e aft er thrombolysis for many years. Brass et al 1 analysed risk factors of intracranial haemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial ischaemia. They found independent predictors such as age 75 years, black race, history of stroke, systolic blood pressure 160 mmHg, rtPA use, anticoagulant use, and below median weight. In stroke patients with thrombolysis, the risk factors of cerebral haemorrhage are presumed to be identical.
Neumann-Haefelin et al 2 evaluated data from acute anterior circulation stroke patients treated with thrombolysis and reported leukoaraiosis of the deep white matter as an independent risk factor for sy mpt oma tic intr acereb ra l h aemorr hag e aft er thrombolytic treatment for acute stroke. Trouillas and colleague 3 classified cerebral haemorrhages after thrombolysis in ischaemic stroke into three types  haemorrhagic infarct, parenchymal haemorrhage, and extraischaemic haematoma (haematoma being remote from ischaemic infarct). The potential main causes of these three types of cerebral haemorrhage were ischaemia, thrombolytic, and cerebral amyloid angiopathy, respectively.
The cause and effect relationship between thrombolysis and early cerebral haemorrhage is generally accepted when prior ischaemic area bleeds. Although leukoaraiosis or cerebral amyloid angiopathy explains most of the lobar haemorrhages after thrombolysis, they do not explain why thrombolysis for anterior circulation stroke resulted in posterior circulation haemorrhage. Cerebral amyloid angiopathy typically involves the cortex and lobar region in individuals older than 60 years and rarely caused pontine haemorrhage. 4 Other differential diagnoses such as vasculitis and blood dyscrasias could be excluded by MRA and blood examinations.
In our patients, the unexpected haemorrhage location is extraischaemic according to Trouillas and colleagues' classification. 3 Extremely high blood pressure may help explain cerebral haemorrhages in these two patients. The haemorrhage location in our patients, i.e., pons and thalamus, are the two most common locations of hypertensive haemorrhage. Chronic hypertension leads to lipohyalinosis and Charcot-Bouchard aneurysms of cerebral penetrating arteries. 5 Once these fragile arterioles are damaged by high blood pressure, hypertensive haemorrhage develops. Therefore it is important to intensively monitor and tightly control the blood pressure during and following thrombolytic therapy for acute ischaemic stroke.
Conclusion
In summary, we presumed that our patients' brainstem haemorrhages were associated with extremely high blood pressure during and after rtPA infusion. Extremely high blood pressure during thrombolytic therapy not only increases possibility of haemorrhagic transformation of ischaemic infarction but also chance of intraparenchymal haemorrhage.
